Adverum Biotechnologies (ADVM) Received its Third Buy in a Row

After SunTrust Robinson and Piper Sandler gave Adverum Biotechnologies (NASDAQ: ADVM) a Buy rating last month, the company received another Buy, this time from Chardan Capital. Analyst Gbola Amusa reiterated a Buy More »

The Chief Commercial Officer of GW Pharma is Exercising Options

Today it was reported that the Chief Commercial Officer of GW Pharma (GWPH – Research Report), Darren Cline, exercised options to sell 150 GWPH shares for a total transaction value of $18.97K. More »